These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31081402)

  • 1. Bacteriophage Therapy of Chronic Nonhealing Wound: Clinical Study.
    Gupta P; Singh HS; Shukla VK; Nath G; Bhartiya SK
    Int J Low Extrem Wounds; 2019 Jun; 18(2):171-175. PubMed ID: 31081402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds.
    Mendes JJ; Leandro C; Corte-Real S; Barbosa R; Cavaco-Silva P; Melo-Cristino J; Górski A; Garcia M
    Wound Repair Regen; 2013; 21(4):595-603. PubMed ID: 23755910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care.
    Seth AK; Geringer MR; Nguyen KT; Agnew SP; Dumanian Z; Galiano RD; Leung KP; Mustoe TA; Hong SJ
    Plast Reconstr Surg; 2013 Feb; 131(2):225-234. PubMed ID: 23357984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Customized Bacteriophages in the Treatment of Chronic Nonhealing Wounds: A Prospective Study.
    Patel DR; Bhartiya SK; Kumar R; Shukla VK; Nath G
    Int J Low Extrem Wounds; 2021 Mar; 20(1):37-46. PubMed ID: 31752578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus.
    Kifelew LG; Warner MS; Morales S; Vaughan L; Woodman R; Fitridge R; Mitchell JG; Speck P
    BMC Microbiol; 2020 Jul; 20(1):204. PubMed ID: 32646376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
    Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
    Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage therapy reduces
    Molendijk MM; Boekema BKHL; Lattwein KR; Vlig M; Bode LGM; Koopmans MPG; Verbon A; de Graaf M; van Wamel WJB
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0065024. PubMed ID: 39136463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of bactericidal effects of bacteriophage and gentamicin combination regimen against Staphylococcus aureus and Pseudomonas aeruginosa strains in a mice diabetic wound model.
    Jokar J; Abdulabbas HT; Javanmardi K; Mobasher MA; Jafari S; Ghasemian A; Rahimian N; Zarenezhad A; ُSoltani Hekmat A
    Virus Genes; 2024 Feb; 60(1):80-96. PubMed ID: 38079060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds.
    Zhao G; Hochwalt PC; Usui ML; Underwood RA; Singh PK; James GA; Stewart PS; Fleckman P; Olerud JE
    Wound Repair Regen; 2010; 18(5):467-77. PubMed ID: 20731798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
    Jacobsen F; Fisahn C; Sorkin M; Thiele I; Hirsch T; Stricker I; Klaassen T; Roemer A; Fugmann B; Steinstraesser L
    Antimicrob Agents Chemother; 2011 May; 55(5):2325-34. PubMed ID: 21343458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.
    Merabishvili M; Pirnay JP; Verbeken G; Chanishvili N; Tediashvili M; Lashkhi N; Glonti T; Krylov V; Mast J; Van Parys L; Lavigne R; Volckaert G; Mattheus W; Verween G; De Corte P; Rose T; Jennes S; Zizi M; De Vos D; Vaneechoutte M
    PLoS One; 2009; 4(3):e4944. PubMed ID: 19300511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.
    Pallavali RR; Degati VL; Lomada D; Reddy MC; Durbaka VRP
    PLoS One; 2017; 12(7):e0179245. PubMed ID: 28719657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials.
    Taati Moghadam M; Khoshbayan A; Chegini Z; Farahani I; Shariati A
    Drug Des Devel Ther; 2020; 14():1867-1883. PubMed ID: 32523333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages for Chronic Wound Treatment: from Traditional to Novel Delivery Systems.
    Pinto AM; Cerqueira MA; Bañobre-Lópes M; Pastrana LM; Sillankorva S
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32093349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of bacteriophages for treatment of wound infections.
    Chang RYK; Morales S; Okamoto Y; Chan HK
    Transl Res; 2020 Jun; 220():153-166. PubMed ID: 32268129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of microbiological quantitative methods for evaluation of changes in the amount of bacteria in patients with wounds and purulent fistulas subjected to phage therapy and for assessment of phage preparation effectiveness (in vitro studies).
    Lecion D; Fortuna W; Dąbrowska K; Międzybrodzki R; Weber-Dąbrowska B; Górski A
    Adv Med Sci; 2013; 58(2):257-64. PubMed ID: 24216162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Feasibility of Using Commercial Wound Coatings as a Carrier Matrix for Bacteriophages.
    Beschastnov VV; Shirokova IY; Belyanina NA; Pogodin IE; Tulupov AA; Tochilina AG; Belova IV; Tyumenkov YO; Kovalishena OV; Soloveva IV
    Sovrem Tekhnologii Med; 2024; 16(1):45-52. PubMed ID: 39421627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage entrapped chitosan microgel for the treatment of biofilm-mediated polybacterial infection in burn wounds.
    Dehari D; Kumar DN; Chaudhuri A; Kumar A; Kumar R; Kumar D; Singh S; Nath G; Agrawal AK
    Int J Biol Macromol; 2023 Dec; 253(Pt 5):127247. PubMed ID: 37802451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage therapy as an alternative technique for treatment of multidrug-resistant bacteria causing diabetic foot infection.
    Ghanaim AM; Foaad MA; Gomaa EZ; Dougdoug KAE; Mohamed GE; Arisha AH; Khamis T
    Int Microbiol; 2023 May; 26(2):343-359. PubMed ID: 36350460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.